002198SZSE
🚨 Material Event

Announcement on Abnormal Fluctuations in Stock Trading

ST Jiaying Co., Ltd.··3 pages

✨ AI Summary

Guangdong Jiayao Pharmaceutical Co., Ltd. announces abnormal stock price fluctuations, with a cumulative increase of 12.66% over two trading days. The company has no controlling shareholder and no undisclosed material events. It is subject to other risk warnings due to a qualified internal control audit opinion, with trading limits reduced to 5%.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 002198

Stock Abbreviation: ST Jiayao

Announcement Number: 2026-030

Guangdong Jiayao Pharmaceutical Co., Ltd.

Announcement on Abnormal Fluctuations in Stock Trading

The company and all members of its board of directors guarantee the truthfulness, accuracy, and completeness of the contents of this announcement, and that there are no false records, misleading statements, or material omissions.

Special Risk Warning:

● Guangdong Jiayao Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") stock (Stock Abbreviation: ST Jiayao, Stock Code: 002198) experienced a cumulative price increase deviation of 12.66% over two consecutive trading days (July 1, 2026, and July 2, 2026). In accordance with the "Trading Rules of the Shenzhen Stock Exchange," this constitutes an abnormal fluctuation in stock trading.

● The Company currently has no controlling shareholder or actual controller. After self-inspection, the Company has no major undisclosed matters and no major matters under planning.

● Due to an internal control audit for 2025 conducted by the Company's accounting firm, Zhonghua Certified Public Accountants (Special General Partnership), which resulted in a qualified opinion on internal financial reporting controls, the Shenzhen Stock Exchange has imposed other risk warnings on the Company's stock trading in accordance with Article 9.8.1 (IV) of the "Shenzhen Stock Exchange Stock Listing Rules." The Company's stock was suspended for one trading day on April 30, 2026 (Thursday) and resumed trading on May 6, 2026 (Wednesday). Since resuming trading on May 6, 2026, the Shenzhen Stock Exchange has imposed other risk warnings on the Company's stock. The stock abbreviation has changed from "Jiayao Pharmaceutical" to "ST Jiayao," and the daily trading limit has been reduced from 10% to 5%. The Company is working hard to eliminate the impact of related adverse factors to improve the effectiveness of its internal control operations and protect the legitimate rights and interests of the Company and its shareholders.

● The Company's current daily operations are normal, with no significant changes. The stock price has fluctuated significantly in the short term. Investors are kindly reminded to pay attention to the risks of secondary market trading, make rational decisions, and invest prudently.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.